Article
Osteoarthritis gene therapy in 2022
9 Nov 2022
Abstract excerpt
PURPOSE OF REVIEW: To assess the present status of gene therapy for osteoarthritis (OA). RECENT FINDINGS: An expanding list of cDNAs show therapeutic activity when introduced into the joints of animals with experimental models of OA. In vivo delivery with adenovirus or adeno-associated virus is most commonly used for this purpose. The list of encoded products includes cytokines, cytokine antagonists, enzymes,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
